PDF herunterladen
Thromb Haemost 2017; 117(10): 2006-2007
DOI: 10.1160/TH17-04-0251
Letter to the Editor
Schattauer GmbH

Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions

Antonio Girolami
1   University of Padua Medical School, Department of Medicine, Padua, Italy
,
Silvia Ferrari
1   University of Padua Medical School, Department of Medicine, Padua, Italy
,
Elisabetta Cosi
1   University of Padua Medical School, Department of Medicine, Padua, Italy
,
Bruno Girolami
1   University of Padua Medical School, Department of Medicine, Padua, Italy
2   Division of Medicine, Padua City Hospital, Padua, Italy
› Institutsangaben Financial support: This study was supported in part by the “Associazione Emofilia ed altre Coagulopatie delle Tre Venezie”.
Weitere Informationen

Publikationsverlauf

Received: 11. April 2017

Accepted after major revision: 21. Juni 2017

Publikationsdatum:
28. November 2017 (online)

    Lizenzen und Reprints

Comment on Ding et al. Thromb Haemost 2017; 117: 479–490.

 

  • References

  • 1 Ding Q, Yang L, Zhao X. et al. Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation. Thromb Haemost 2017; 117: 479-490.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 2 Kalina U, Bickhard H, Schulte S. Biochemical comparison of seven commercially available prothrombin complex concentrates. Int J Clin Pract 2008; 62: 1614-1622.
    CrossrefPubMedGoogle Scholar
  • 3 Samama CM. Prothrombin complex concentrates: a brief review. Eur J Anaesthesiol 2008; 25: 784-789.
    CrossrefPubMedGoogle Scholar
  • 4 Lusher JH. Thrombogenicity associated with factor IX complex concentrates. Semin Hematol 1991; 28: 3-5.
    PubMedGoogle Scholar
  • 5 Girolami A, Ruzzon E, Fabris F. et al. Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006; 116: 120-125.
    CrossrefPubMedGoogle Scholar
  • 6 Miyawaki Y, Suzuki A, Fujita J. et al. Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med 2012; 366: 2390-2396.
    CrossrefPubMedGoogle Scholar
  • 7 Djordjevic V, Kovac M, Miljic P. et al. A novel prothrombin mutation in two families with prominent thrombophilia – the first cases of antithrombin resistance in a Caucasian population. J Thromb Haemost 2013; 11: 1936-1939.
    CrossrefPubMedGoogle Scholar
  • 8 Kishimoto M, Suzuki N, Murata M. et al. The first case of antithrombin-resistant prothrombin Belgrade mutation in Japanese. Ann Hematol 2016; 95: 541-542.
    CrossrefPubMedGoogle Scholar
  • 9 Bulato C, Radu CM, Campello E. et al. New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism. Arterioscler Thromb Vasc Biol 2016; 36: 1022-1029.
    CrossrefPubMedGoogle Scholar
  • 10 Akhavan S, De Cristofaro R, Peyvandi F. et al. Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype. Blood 2002; 100: 1347-1353.
    CrossrefPubMedGoogle Scholar
  • 11 Henriksen RA, Owen WG, Nesheim ME. et al. Identification of a congenital dysthrombin, thrombin Quick. J Clin Invest 1980; 66: 934-940.
    CrossrefPubMedGoogle Scholar
  • 12 O’Marcaigh AS, Nichols WL, Hassinger NL. et al. Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia. Blood 1996; 88: 2611-2618.
    PubMedGoogle Scholar
  • 13 Girolami A, Tezza F, Scandellari R. et al. Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature. J Thromb Thrombolysis 2010; 30: 172-8.
    CrossrefPubMedGoogle Scholar
  • 14 Girolami A, Cosi E, Tasinato V. et al. Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies. Blood Coagul Fibrinolysis 2016; 27: 517-25.
    CrossrefPubMedGoogle Scholar
  • 15 Girolami A, Bertozzi I, Rigoni I. et al. Congenital FVII deficiency and thrombotic events after replacement therapy. J Thromb Thrombolysis 2011; 32: 362-367.
    CrossrefPubMedGoogle Scholar